Role of plasma high-sensitivity C-reactive protein in patients with metabolic syndrome

Downloads

Download data is not yet available.
PDF (Tiếng Việt)     4    0

Abstract

Background: Metabolic syndrome (MetS) is characterized by abdominal obesity, dyslipidemia, hypertension, glucose intolerance and is associated with an increased risk of developing cardiovascular disease, diabetes mellitus and related diseases. Elevated levels of high-sensitivity C-reactive protein (hsCRP) are associated with an increased waist circumference, insulin resistance, body mass index (BMI) and hyperglycemia and are increased with the number of the MetS components. Plasma hs-CRP levels independently predicted the occurrence of future cardiovascular disease events and may be an important independent predictor of unfavourable outcomes in the MetS.
Objective: Find out what risk factors for metabolic syndrome were associated with increased plasma
hs-CRP levels.
Material and method: A cross sectional study with control group on 303 adult subjects for health examinations at International Medical Center at Hue Central Hospital, including 108 subjects with metabolic syndrome and control group of 195 subjects without metabolic syndrome Metabolic syndrome was defined according to the IDF, NHLBI, AHA, WHF, IAS, IASO (2009). Anthropometric factors and biochemical parameters (hs-CRP, total cholesterol, triglycerides, HDL-L, LDL-C, fasting blood glucose and HbA1C) were determined. Univariate and multivariate analyses were conducted to evaluate the association of hs-CRP and MetS.
Results: BMI, waist circumference, HbA1C, HDL-C, systolic blood pressure and MetS were associated with increased plasma hs-CRP levels (p <0,05 to p <0,001). In particular, HbA1C, HDL-C and systolic blood pressure were independent risk factors for increasing plasma hs-CRP levels (p <0,05 to p <0,001).

https://doi.org/10.38103/jcmhch.2020.61.7

References

Binh TQ, Phuong PT, Nhung BT (2014), “Metabolic syndrome among a middle-aged population in the Red River Delta region of Vietnam”, BMC endocrine disorders. 14 (1), pp. 77.

Bộ Y tế (2013), Nội tiết chuyển hóa, Nhà xuất bản Y học, tr 355.

Brunner EJ, Kivimäki M, Witte DR, Lawlor DA, Smith GD, Cooper JA et al (2008), “Inflammation, insulin resistance, and diabetes - Mendelian randomization using CRP haplotypes points upstream”, PLoS medicine. 5 (8)].

Ngô Đình Châu, Trần Hữu Dàng, Trần Trung Thông (2009), “Nghiên cứu nồng độ CRP máu trên đối tượng hội chứng chuyển hóa”, Tạp chí

nội khoa, Kỷ yếu toàn văn các đề tài khoa học hội nghị tim mạch miền Trung mở rộng lần thứ V, tr. 913 - 916.

Chowta MN, Adhikari PM, Sinha R, Acharya SD, Gopalakrishna H, Ramapuram JT (2012), “Highly sensitive C reactive protein in patients

with metabolic syndrome and cardiovascular disease”, Annals of Tropical Medicine and Public Health. 5 (2), pp. 98 - 102.

Fröhlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, et al (2000), “Association between C-reactive protein and features of

the metabolic syndrome: a population-based study”, Diabetes care. 23 (12), pp. 1835 - 1839.

Trần Quang Huy, Trần Quốc Việt, Lương Cao Đồng, Phạm Văn Trân (2017), “Nghiên cứu mối liên quan giữa hs-CRP máu với một số yếu tố

nguy cơ tim mạch ở người có hội chứng chuyển hóa”, Y Học TP. Hồ Chí Minh, 16(3), tr. 17 - 22.

Nguyễn Thị Hường, Đoàn Phước Thuộc, Lê Văn Chi (2018), Giá trị của vòng bụng và tỷ vòng bụng/vòng mông trong tiên đoán hội chứng

chuyển hóa của người dân tại hai xã của huyện Quảng Điền, tỉnh Thừa Thiên Huế, Tạp chí Y Dược học, tập 8, số 6, tr 27 - 33.

Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K et al 2004), “Hypoadiponectinemia Is an Independent Risk Factor for Hypertension”, Hypertension. 43 (6), pp. 1318 - 1323.

Kaur J. (2014), “A comprehensive review on metabolic syndrome”, Cardiology research and practice. 2014.

Klisic AN, Vasiljevic ND, Simic TP, Djukic TI, Maksimovic MZ, Matic MG (2014), “Association Between C-Reactive Protein, Anthropometric and Lipid Parameters Among Healthy Normal Weight and Overweight Postmenopausal Women in Montenegro”, Laboratory Medicine. 45 (1), pp. 12 - 16.

Krentz AJ, Scuteri A (2017), “Insulin resistance and the metabolic syndrome”, Diabetes in Old Age, pp. 177 - 212.

Kunii D, Hung NTK, Sakai T, Yamamoto S et al (2005), “The metabolic syndrome: prevalence and risk factors in the urban population of Ho Chi Minh City”, Diabetes research and clinical practice. 67 (3), pp. 243 - 250.

Manjunath D, Uthappa CK, Kattula SR, Allam RR, Chava N, Oruganti G (2014), “Metabolic syndrome among urban Indian young adults:

prevalence and associated risk factors”, Metabolic Syndrome and Related Disorders. 12 (7), pp. 381 - 389.

Mirhafez SR, Ebrahimi M, Saberi Karimian M, Avan A, Tayefi M, Heidari-Bakavoli A et al (2016), “Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects”, European journal of clinical nutrition. 70 (11), pp. 1298 - 1304.

Pan A, Wang Y, Yuan J-M, Koh W-P (2017), “High-sensitive C-reactive protein and risk of incident type 2 diabetes: a case–control study

nested within the Singapore Chinese Health Study”, BMC endocrine disorders. 17 (1), pp. 8

Rensburg MA, Matsha T, Hoffmann M, Hassan MS, Erasmus RT (2012), “Distribution and association of hs-CRP with cardiovascular risk

variables of metabolic syndrome in adolescent learners”, African journal of laboratory medicine. 1 (1), pp. 10 - 10.

Riaz M, Fawwad A, Hydrie MZI, Basit A, Shera AS (2011), “Is There Any Association of Serum High-Sensitivity C-Reactive Protein with

Various Risk Factors for Metabolic Syndrome in a Healthy Adult Population of Karachi, Pakistan?”, Metabolic Syndrome and Related

Disorders. 9 (3), pp. 177 - 182.

Shea JL, King MTC, Yi Y, Gulliver W, Sun G (2012), “Body fat percentage is associated with cardiometabolic dysregulation in BMI-defined

normal weight subjects”, Nutrition, Metabolism and Cardiovascular Diseases. 22 (9), pp. 741 - 747.

Shin SH, Lee YJ, Lee YA, Kim JH, Lee SY, Shin CH (2019), “High-Sensitivity C-Reactive Protein Is Associated with Prediabetes and Adiposity in Korean Youth”, Metabolic Syndrome and Related Disorders. 18 (1), pp. 47 - 55.

Hoàng Anh Tiến, Lê Kim Phượng (2015), “Nghiên cứu nồng độ hs-CRP trên người dân Thành phố Huế”, Tạp chí Y Dược học, 25, tr.

- 43.

Wang Z, Nakayama T (2010), “Inflammation, a link between obesity and cardiovascular disease”, Mediators of inflammation. 2010.

Zuliani G, Volpato S, Galvani M, Blè A, Bandinelli S, Corsi AM et al (2009), “Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study”, Atherosclerosis. 203 (2), pp. 626 - 632.

Published 18-01-2025
Fulltext
PDF (Tiếng Việt)     4    0
Language
Issue No. 61 (2020)
Section Original article
DOI 10.38103/jcmhch.2020.61.7
Keywords Hội chứng chuyển hóa, protein phản ứng C độ nhạy cao Metabolic syndrome, high-sensitivity C-reactive protein

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2020 Journal of Clinical Medicine Hue Central Hospital

Nghia, N. T., Huong, H. T. L., Hieu, P. T., Tien, B. T. T., & Chi, N. T. Q. (2025). Role of plasma high-sensitivity C-reactive protein in patients with metabolic syndrome. Journal of Clinical Medicine Hue Central Hospital, (61), 47–53. https://doi.org/10.38103/jcmhch.2020.61.7